Company / Working Capital per Share
Nurix Therapeutics, Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.86
FY2025
5-year range
$4.42 / $10.75
FY2021-FY2025
Trend
-36.2%
vs FY2024
Sector context
#77 of 210
Health Care
What the data says
At $6.86, Nurix Therapeutics, Inc.'s working capital per share ranks #77 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 7 years, ranging from $4.42 in FY2023 to $70.62 in FY2020.
Based on SEC 10-K filings.
6.86 in FY2025 with a 5-year CAGR of -37.3%.
Improved from $4.42 to $6.86 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +7.3%
- 5-Year CAGR
- -37.3%
- 10-Year CAGR
- -
Sector benchmark
#77 of 210 in Health CareTop 37% of 210This company $6.86 Sector average $118.60
▼
-94.2% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 36.2% year-over-year.
- Ranks #77 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.86 | -36.2% |
| FY2024 | $10.75 | +143.1% |
| FY2023 | $4.42 | -20.3% |
| FY2022 | $5.55 | -11.9% |
| FY2021 | $6.30 | -91.1% |
| FY2020 | $70.62 | +901.5% |
| FY2019 | $7.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026